NCT04469621 - A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions

Corona Virus Infection

Interventions

DRUG

SAR443122

Pharmaceutical form:capsule Route of administration: oral

DRUG

Placebo

Pharmaceutical form:capsule Route of administration: oral

Trial Locations (10)

Investigational Site Number 0320001, Caba

Investigational Site Number 4840001, Monterrey

Investigational Site Number 6430001, Moscow

Investigational Site Number 6430002, Moscow

Investigational Site Number 1520002, Talca

Investigational Site Number 1520003, Santiago

Investigational Site Number 0760003, Porto Alegre

Investigational Site Number 0760001, São José do Rio Preto

Investigational Site Number 0760002, São Paulo

Investigational Site Number 1520001, Santiago